Harrow (HROW) Revenue (2013 - 2026)
Harrow (HROW) recorded quarterly Revenue of $44.2 million in Q1 2026, down 50.38% quarter-over-quarter from $89.1 million in Q4 2025, and down 7.59% on a YoY basis from $47.8 million in Q1 2025.
Harrow (HROW) Revenue (2013 - 2026) Analysis & Trends
Harrow's Revenue history runs 14 years deep, the most recent figure standing at $44.2 million for Q1 2026.
- In Q1 2026, Revenue fell 7.59% year-over-year to $44.2 million; the TTM figure through Mar 2026 stood at $268.7 million (up 26.22% YoY), while the FY2025 annual figure was $272.3 million, up 36.41% from the prior year.
- Revenue was $44.2 million for Q1 2026 at Harrow, down from $89.1 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $89.1 million in Q4 2025 to a low of $20.3 million in Q4 2022.
- Historically, Revenue has averaged $43.2 million across 5 years, with a median of $36.4 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Revenue soared 83.83% in 2024, then retreated 7.59% in 2026.
- A 5-year view of Revenue shows it stood at $20.3 million in 2022, then soared by 78.83% to $36.4 million in 2023, then jumped by 83.83% to $66.8 million in 2024, then soared by 33.31% to $89.1 million in 2025, then slumped by 50.38% to $44.2 million in 2026.
- The last three Revenue figures came in at $44.2 million (Q1 2026), $89.1 million (Q4 2025), and $71.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 377.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 608.10 Mn |
| 10 | Harrow | 1.23 Bn | 1.14 Bn | 27.05 Mn | 44.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.20 Mn |
| Dec 31, 2025 | 89.09 Mn |
| Sep 30, 2025 | 71.64 Mn |
| Jun 30, 2025 | 63.74 Mn |
| Mar 31, 2025 | 47.83 Mn |
| Dec 31, 2024 | 66.83 Mn |
| Sep 30, 2024 | 49.26 Mn |
| Jun 30, 2024 | 48.94 Mn |
| Mar 31, 2024 | 34.59 Mn |
| Dec 31, 2023 | 36.36 Mn |
| Sep 30, 2023 | 34.27 Mn |
| Jun 30, 2023 | 33.47 Mn |
| Mar 31, 2023 | 26.10 Mn |
| Dec 31, 2022 | 20.33 Mn |
| Sep 30, 2022 | 22.82 Mn |
| Jun 30, 2022 | 23.32 Mn |
| Mar 31, 2022 | 22.12 Mn |
| Dec 31, 2021 | 20.19 Mn |
| Sep 30, 2021 | 18.71 Mn |
| Jun 30, 2021 | 18.13 Mn |